Release 5 Preview #1

This page is part of the FHIR Specification (v4.2.0: R5 Preview #1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3

4.4.1.506 Value Set http://hl7.org/fhir/ValueSet/adverse-event-causality-assess

Patient Care Work Group Maturity Level: 1Draft Use Context: Any

This is a value set defined by the FHIR project.

Summary

Defining URL:http://hl7.org/fhir/ValueSet/adverse-event-causality-assess
Version:4.2.0
Name:AdverseEventCausalityAssessment
Title:AdverseEventCausalityAssessment
Definition:

Codes for the assessment of whether the entity caused the event.

Committee:Patient Care Work Group
OID:2.16.840.1.113883.4.642.3.840 (for OID based terminology systems)
Source ResourceXML / JSON

This value set is used in the following places:

4.4.1.506.1 Content Logical Definition

This value set includes codes from the following code systems:

 

4.4.1.506.2 Expansion

This expansion generated 31 Dec 2019

This value set contains 6 concepts

Expansion based on http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess version 4.2.0

All codes from system http://terminology.hl7.org/CodeSystem/adverse-event-causality-assess

CodeDisplayDefinition
certainCertaini) Event or laboratory test abnormality, with plausible time relationship to drug intake; ii) Cannot be explained by disease or other drugs; iii) Response to withdrawal plausible (pharmacologically, pathologically); iv) Event definitive pharmacologically or phenomenologically (i.e. an objective and specific medical disorder or a recognized pharmacological phenomenon); or v) Re-challenge satisfactory, if necessary.
probably-likelyProbably/Likelyi) Event or laboratory test abnormality, with reasonable time relationship to drug intake; ii) Unlikely to be attributed to disease or other drugs; iii) Response to withdrawal clinically reasonable; or iv) Re-challenge not required.
possiblePossiblei) Event or laboratory test abnormality, with reasonable time relationship to drug intake; ii) Could also be explained by disease or other drugs; or iii) Information on drug withdrawal may be lacking or unclear.
unlikelyUnlikelyi) Event or laboratory test abnormality, with a time to drug intake that makes a relationship improbable (but not impossible); or ii) Disease or other drugs provide plausible explanations.
conditional-classifiedConditional/Classifiedi) Event or laboratory test abnormality; ii) More data for proper assessment needed; or iii) Additional data under examination.
unassessable-unclassifiableUnassessable/Unclassifiablei) Report suggesting an adverse reaction; ii) Cannot be judged because information is insufficient or contradictory; or iii) Data cannot be supplemented or verified.

 

See the full registry of value sets defined as part of FHIR.

Explanation of the columns that may appear on this page:

LvlA few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information
SourceThe source of the definition of the code (when the value set draws in codes defined elsewhere)
CodeThe code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract')
DisplayThe display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
DefinitionAn explanation of the meaning of the concept
CommentsAdditional notes about how to use the code